Answers are grounded in this paper and cite their sources.
Endometriosis is a chronic, multifactorial disease affecting around 10% of women worldwide and is often accompanied by systemic inflammation, comorbidities, and reduced quality of life. Using the All of Us database, we conducted a large-scale analysis to characterize demographic and clinical features of women with endometriosis and evaluate the impact of inflammatory conditions and mental health conditions. To conduct these studies we created two cohorts; cohort A aimed to establish associations between inflammatory conditions and endometriosis, while cohort B was used to study the impact of endometriosis on mental health and quality of life outcomes. In cohort A, a history of inflammatory conditions (asthma, inflammatory bowel disease (IBD), or migraine) was associated with higher odds of incident endometriosis (adjusted odds ratio = 3.06, 95% CI: 2.92-3.20, p < 0.0001). Women with inflammatory comorbidities were diagnosed at a younger age (42.9 ± 11.2 vs. 44.9 ± 12.1 years), suggesting earlier recognition or onset. In cohort B, participants with endometriosis had higher odds of EHR-documented depression (age-adjusted odds ratio = 2.29, 95% CI: 2.17-2.41) and anxiety (age-adjusted odds ratio = 2.44, 95% CI: 2.32-2.57). Participants with endometriosis also reported poorer general health, physical health, mental health, social satisfaction, and overall quality of life, with all five associations remaining statistically significant after adjustment for age, race, ethnicity, and household income (all p < 0.001). These findings underscore the interplay among systemic inflammation, early disease manifestations, and psychosocial burden in endometriosis, offering population-level insights to inform early detection strategies and promote equitable, multidisciplinary care for affected women.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: